Table of Contents Table of Contents
Previous Page  917 1030 Next Page
Information
Show Menu
Previous Page 917 1030 Next Page
Page Background

[11]

Rogers CG, Khan MA, Craig Miller M, Veltri RW, Partin AW. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radi- cal prostatectomy. Cancer 2004;101:2549–56.

[12]

Bolla M, van Poppel H, Tombal B, et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long- term results of a randomised controlled trial (EORTC trial 22911). Lancet 2012;380:2018–27.

[13]

Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow up of a randomized clinical trial. J Urol 2009;181:956–62.

[14]

van Stam MA, Aaronson NK, Pos FJ, et al. The effect of salvage radiotherapy and its timing on the health-related quality of life of prostate cancer patients. Eur Urol 2016;70:751–7

.

[15]

Zaffuto E, Gandaglia G, Fossati N, et al. Early postoperative radio- therapy is associated with worse functional outcomes in patients with prostate cancer. J Urol 2017;197(3 Pt 1):669–75.

[16]

Gandaglia G, Briganti A, Clarke N, et al. Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients. Eur Urol 2017;72:689–709.

[17]

Tendulkar RD, Agrawal S, Gao T, et al. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy. J Clin Oncol 2016;34:3648–54.

[18]

Abdollah F, Karnes RJ, Suardi N, et al. Impact of adjuvant radiother- apy on survival of patients with node-positive prostate cancer. J Clin Oncol 2014;32:3939–47.

[19]

Briganti A, Karnes RJ, Da Pozzo LF, et al. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. Eur Urol 2011;59:832–40.

[20]

Suardi N, Gallina A, Lista G, et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatec- tomy. Eur Urol 2014;65:546–51.

[21]

Cleveland W. LOWESS: a program for smoothing scatterplots by robust locally weighted regression. Am Stat 1981;35:54.

[22]

Lohm G, Bottke D, Jamil B, et al. Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results. World J Urol 2013;31:423–8.

[23]

Perera M, Papa N, Christidis D, et al. Sensitivity, specificity, and predictors of positive 68ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis. Eur Urol 2016;70:926–37

.

[24]

Freedland SJ, Choeurng V, Howard L, et al. Utilization of a genomic classifier for prediction of metastasis following salvage radiation therapy after radical prostatectomy. Eur Urol 2016;70: 588–96

.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 9 1 0 – 9 1 7

917